What is imaware?
Imaware operates a sophisticated diagnostics platform that facilitates personalized health management through a robust ecosystem of at-home and laboratory testing solutions. By integrating advanced biomarker analysis with customizable wellness programs, the company serves a broad spectrum of stakeholders, ranging from health systems and payors to employers and pharmaceutical entities. The platform is engineered to streamline operational workflows while delivering actionable, data-driven health insights. In an era where corporate wellness and preventative care are increasingly prioritized, Imaware provides the essential digital and physical infrastructure required to foster deeper user engagement and improve long-term health outcomes through precision diagnostics.
How much funding has imaware raised?
imaware has raised a total of $15M across 1 funding round:
Angel/Seed
$15M
Angel/Seed (2022): $15M with participation from Christian Reber, Naren Shaam, Lakestar, June Fund, Lucas von Cranach, and Cherry Ventures
Key Investors in imaware
Lakestar
Lakestar is a venture capital firm dedicated to partnering with visionary tech entrepreneurs to fund innovative ideas and companies that shape modern life, with a focus on sectors such as Deep Tech and Healthcare.
June Fund
June Fund is a global technology investor backed by leading industrial minds, focusing on new paradigms across networks, infrastructure, and open software platforms.
Cherry Ventures
Cherry Ventures is a Berlin-based firm founded by former entrepreneurs that provides early-stage capital and operational expertise to startups across various high-growth industries.
What's next for imaware?
With this major strategic investment, Imaware is well-positioned to accelerate its product roadmap and deepen its penetration within the enterprise health sector. The company is expected to focus on scaling its diagnostic operations, enhancing its proprietary data analytics engine, and forging new partnerships with large-scale health systems. As the demand for decentralized, patient-centric care models continues to rise, Imaware's ability to provide seamless, high-quality testing at scale will be a key differentiator. Future growth will likely center on expanding its biomarker library and refining its personalized recommendation algorithms to maintain its competitive edge in the rapidly evolving digital health landscape.
See full imaware company page
